PRECIGEN, INC. Capital Expenditures
PRECIGEN, INC. (PGEN) reported Capital Expenditures of $650.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-04
- PRECIGEN, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $392.00K, a 59.42% decline year-over-year.
- PRECIGEN, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $258.00K, a 58.52% decline year-over-year.
- PRECIGEN, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $18.00K, a 98.25% decline year-over-year.
- PRECIGEN, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $389.00K, a 55.90% decline year-over-year.
- PRECIGEN, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $2.00M, a 76.76% decline from fiscal 2024.
- PRECIGEN, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $8.58M, a 458.85% increase from fiscal 2023.
- PRECIGEN, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $1.54M, a 68.81% decline from fiscal 2022.
- PRECIGEN, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $4.92M, a 32.05% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $392.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $650.00K 10-Q · filed 2026-08-04 | $668.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.06M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $258.00K 10-Q · filed 2026-05-13 | $276.00K derived: sum of 2 quarters · filed 2026-05-13 | $665.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.63M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $407.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.37M derived: sum of 3 quarters · filed 2026-08-04 | $2.00M 10-K · filed 2026-03-25 |
| 2025-09-30 | $389.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.35M derived: sum of 2 quarters · filed 2026-08-04 | $1.98M 10-Q · filed 2025-11-13 | $3.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $966.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.59M 10-Q · filed 2026-08-04 | $2.62M derived: sum of 3 quarters · filed 2026-08-04 | $3.50M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $622.00K 10-Q · filed 2026-05-13 | $1.65M derived: sum of 2 quarters · filed 2026-05-13 | $2.53M derived: sum of 3 quarters · filed 2026-05-13 | $4.86M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.91M derived: sum of 2 quarters · filed 2026-03-25 | $4.23M derived: sum of 3 quarters · filed 2026-03-25 | $8.58M 10-K · filed 2026-03-25 |
| 2024-09-30 | $882.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.21M derived: sum of 2 quarters · filed 2025-11-13 | $7.56M 10-Q · filed 2025-11-13 | $8.60M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $6.67M 10-Q · filed 2025-08-12 | $7.72M derived: sum of 3 quarters · filed 2026-03-25 | $7.96M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $4.35M 10-Q · filed 2025-05-14 | $5.40M derived: sum of 2 quarters · filed 2026-03-25 | $5.63M derived: sum of 3 quarters · filed 2026-03-25 | $5.73M derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.28M derived: sum of 2 quarters · filed 2026-03-25 | $1.38M derived: sum of 3 quarters · filed 2026-03-25 | $1.54M 10-K · filed 2026-03-25 |
| 2023-09-30 | $236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $337.00K derived: sum of 2 quarters · filed 2024-11-14 | $491.00K 10-Q · filed 2024-11-14 | $544.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $255.00K 10-Q · filed 2024-08-14 | $308.00K derived: sum of 3 quarters · filed 2025-03-19 | $1.88M derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-03-31 | $154.00K 10-Q · filed 2024-05-14 | $207.00K derived: sum of 2 quarters · filed 2025-03-19 | $1.78M derived: sum of 3 quarters · filed 2025-03-19 | $3.50M derived: sum of 4 quarters · filed 2025-03-19 |
| 2022-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $1.63M derived: sum of 2 quarters · filed 2025-03-19 | $3.35M derived: sum of 3 quarters · filed 2025-03-19 | $4.92M 10-K · filed 2025-03-19 |
| 2022-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.29M derived: sum of 2 quarters · filed 2023-11-09 | $4.87M 10-Q · filed 2023-11-09 | $7.64M derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-06-30 | $1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.30M 10-Q · filed 2023-08-09 | $6.07M derived: sum of 3 quarters · filed 2024-03-19 | $8.34M derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-03-31 | $1.58M 10-Q · filed 2023-05-10 | $4.35M derived: sum of 2 quarters · filed 2024-03-19 | $6.62M derived: sum of 3 quarters · filed 2024-03-19 | $7.81M derived: sum of 4 quarters · filed 2024-03-19 |
| 2021-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $5.04M derived: sum of 2 quarters · filed 2024-03-19 | $6.23M derived: sum of 3 quarters · filed 2024-03-19 | $7.25M 10-K · filed 2024-03-19 |
| 2021-09-30 | $2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.46M derived: sum of 2 quarters · filed 2022-11-09 | $4.47M 10-Q · filed 2022-11-09 | $5.94M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.21M 10-Q · filed 2022-08-08 | $3.68M derived: sum of 3 quarters · filed 2023-03-06 | $4.70M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $1.01M 10-Q · filed 2022-05-09 | $2.48M derived: sum of 2 quarters · filed 2023-03-06 | $3.51M derived: sum of 3 quarters · filed 2023-03-06 | $5.39M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $2.49M derived: sum of 2 quarters · filed 2023-03-06 | $4.38M derived: sum of 3 quarters · filed 2023-03-06 | $7.53M 10-K · filed 2023-03-06 |
| 2020-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $2.91M derived: sum of 2 quarters · filed 2021-11-08 | $6.06M 10-Q · filed 2021-11-08 | $10.74M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $5.03M 10-Q · filed 2021-08-09 | $9.72M derived: sum of 3 quarters · filed 2022-03-01 | $17.49M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $3.15M 10-Q · filed 2021-05-10 | $7.84M derived: sum of 2 quarters · filed 2022-03-01 | $15.61M derived: sum of 3 quarters · filed 2022-03-01 | $29.51M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $12.46M derived: sum of 2 quarters · filed 2022-03-01 | $26.36M derived: sum of 3 quarters · filed 2022-03-01 | $37.88M 10-K · filed 2022-03-01 |
| 2019-09-30 | $7.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $21.68M derived: sum of 2 quarters · filed 2020-11-09 | $33.20M 10-Q · filed 2020-11-09 | $44.43M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $13.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $25.42M 10-Q · filed 2020-08-10 | $36.66M derived: sum of 3 quarters · filed 2021-03-01 | $45.42M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $11.52M 10-Q · filed 2020-05-11 | $22.76M derived: sum of 2 quarters · filed 2021-03-01 | $31.52M derived: sum of 3 quarters · filed 2021-03-01 | $42.34M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $11.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $20.00M derived: sum of 2 quarters · filed 2021-03-01 | $30.81M derived: sum of 3 quarters · filed 2021-03-01 | $41.59M 10-K · filed 2021-03-01 |
| 2018-09-30 | $8.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $19.58M derived: sum of 2 quarters · filed 2019-11-12 | $30.35M 10-Q · filed 2019-11-12 | $44.34M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $10.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $21.59M 10-Q · filed 2019-08-09 | $35.58M derived: sum of 3 quarters · filed 2020-03-02 | $49.99M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $10.77M 10-Q · filed 2019-05-09 | $24.77M derived: sum of 2 quarters · filed 2020-03-02 | $39.18M derived: sum of 3 quarters · filed 2020-03-02 | $51.10M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $13.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $28.40M derived: sum of 2 quarters · filed 2020-03-02 | $40.32M derived: sum of 3 quarters · filed 2020-03-02 | $46.67M 10-K · filed 2020-03-02 |
| 2017-09-30 | $14.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $26.33M derived: sum of 2 quarters · filed 2018-11-08 | $32.67M 10-Q · filed 2018-11-08 | $44.11M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $11.92M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | $18.26M 10-Q · filed 2018-08-13 | $29.69M derived: sum of 3 quarters · filed 2019-03-01 | $39.85M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $6.34M 10-Q/A · filed 2018-08-13 | $17.77M derived: sum of 2 quarters · filed 2019-03-01 | $27.93M derived: sum of 3 quarters · filed 2019-03-01 | $33.72M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $11.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $21.59M derived: sum of 2 quarters · filed 2019-03-01 | $27.37M derived: sum of 3 quarters · filed 2019-03-01 | $31.63M 10-K · filed 2019-03-01 |
| 2016-09-30 | $10.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $15.94M derived: sum of 2 quarters · filed 2017-11-09 | $20.20M 10-Q · filed 2017-11-09 | $23.11M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $5.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $10.04M 10-Q · filed 2017-08-09 | $12.95M derived: sum of 3 quarters · filed 2018-03-01 | $16.05M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $4.26M 10-Q · filed 2017-05-10 | $7.17M derived: sum of 2 quarters · filed 2018-03-01 | $10.27M derived: sum of 3 quarters · filed 2018-03-01 | $14.29M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $6.01M derived: sum of 2 quarters · filed 2018-03-01 | $10.04M derived: sum of 3 quarters · filed 2018-03-01 | $12.75M 10-K · filed 2018-03-01 |
| 2015-09-30 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $7.13M derived: sum of 2 quarters · filed 2016-11-09 | $9.84M 10-Q · filed 2016-11-09 | $11.02M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $4.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $6.74M 10-Q · filed 2016-08-09 | $7.92M derived: sum of 3 quarters · filed 2017-03-01 | $9.36M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $2.71M 10-Q · filed 2016-05-10 | $3.89M derived: sum of 2 quarters · filed 2017-03-01 | $5.33M derived: sum of 3 quarters · filed 2017-03-01 | $6.10M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.62M derived: sum of 2 quarters · filed 2017-03-01 | $3.39M derived: sum of 3 quarters · filed 2017-03-01 | $6.37M 10-K · filed 2017-03-01 |
| 2014-09-30 | $1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $2.21M derived: sum of 2 quarters · filed 2015-11-09 | $5.19M 10-Q · filed 2015-11-09 | $5.46M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $769.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $3.75M 10-Q · filed 2015-08-10 | $4.02M derived: sum of 3 quarters · filed 2016-02-29 | $4.50M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $2.98M 10-Q · filed 2015-05-11 | $3.25M derived: sum of 2 quarters · filed 2016-02-29 | $3.73M derived: sum of 3 quarters · filed 2016-02-29 | $4.33M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $751.00K derived: sum of 2 quarters · filed 2016-02-29 | $1.35M derived: sum of 3 quarters · filed 2016-02-29 | $1.53M 10-K · filed 2016-02-29 |
| 2013-09-30 | $486.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $1.08M derived: sum of 2 quarters · filed 2014-11-13 | $1.26M 10-Q · filed 2014-11-13 | $1.61M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $595.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $776.00K 10-Q · filed 2014-08-14 | $1.12M derived: sum of 3 quarters · filed 2015-03-02 | $1.30M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $181.00K 10-Q · filed 2014-05-09 | $527.00K derived: sum of 2 quarters · filed 2015-03-02 | $707.00K derived: sum of 3 quarters · filed 2015-03-02 | |
| 2012-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $526.00K derived: sum of 2 quarters · filed 2015-03-02 | $7.49M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $180.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07 | $7.14M 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $6.96M 10-Q/A · filed 2013-10-21 | |||
| 2011-12-31 | $13.00M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |